Report cover image

NA Lymphedema Treatment Market - Industry Trends and Forecast to 2034

Publisher Data Bridge Market Research
Published Sep 01, 2023
Length 143 Pages
SKU # DAABD18286736

Description

NA Lymphedema Treatment Market - Industry Trends and Forecast to 2034


North America Lymphedema Treatment Market is expected to reach USD 1,019,834.36 thousand by 2030 from USD 475,938.11 thousand in 2022 growing at the CAGR of 10.2% in the forecast period of 2023 to 2030.

Market Segmentation:
North America Lymphedema Treatment Market, By Treatment Type (Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others), Treatment (Primary Lymphedema and Secondary Lymphedema), Affected Area (Genital, Lower Extremity, Upper Extremity, and Others), Age Group (Adult and Geriatric), Route of Administration (Oral, Injectable, and Others), End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics, and Others), Distribution Channel (Direct tender, Pharmacy stores, and Others), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2030
Overview of North America Lymphedema Treatment Market Dynamics

Driver
• Increasing number of healthcare facilities

Restrain

• Lack of awareness about the disease

Opportunity

• Partnership and agreement by market players


Market Players

Some of the key market players operating in the North America lymphedema treatment market are listed below:

• medi GmbH & Co. KG
• PAUL HARTMANN AG
• 3M
• Convatec Inc.
• JUZO
• SIGVARIS GROUP
• Sanyleg Srl a socio unico
• AIROS Medical, Inc.
• Tactile Medical
• BIOCOMPRESSION SYSTEMS
• Lohmann & Rauscher GmbH & Co. KG
• Mego Afek ltd.
• ThermoTek
• Cardinal Health
• Essity (BSN medical GmbH)
• Smith+Nephew
• HERANTIS PHARMA Plc
• Huntleigh Healthcare Limited
• Avet Pharmaceuticals Inc
• KOYA MEDICAL

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

143 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Lymphedema Treatment Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel's Analysis
4.2 Porter's Model
5 Pipeline Analysis For North America Lymphedema Treatment Market
6 Epidemiology
7 Regulatory Guidelines For North America Lymphedema Treatment Market
7.1 U.S.
7.2 Europe
7.3 India
7.4 Mexico
7.5 Canada
8 Market Overview
8.1 Drivers
8.1.1 Rise In The Number Of Lymphedema Cases North Americaly
8.1.2 Increase In The Prevalence Of Cancers
8.1.3 Increasing Number Of Healthcare Facilities
8.1.4 Availability Of Multiple Therapies For Lymphedema
8.2 Restraints
8.2.1 High Cost Of Treatment
8.2.2 Lack Of Awareness About The Disease
8.3 Opportunities
8.3.1 Increasing Drug Approvals
8.3.2 Rising Partnerships And Agreements By Major Players
8.4 Challenges
8.4.1 No Permanent Cure For Lymphedema
8.4.2 Limited Reimbursement Scenario
9 North America Lymphedema Treatment Market, By Treatment Type
9.1 Overview
9.2 Compression Therapy
9.2.1 Compression Pumps
9.2.2 Compression Garments
9.2.2.1 Compression Stockings
9.2.2.2 Compression Sleeves
9.2.2.3 Others
9.2.3 Compression Bandages & Wraps
9.2.4 Others
9.2.4.1 Static Compression Therapy
9.2.4.2 Dynamic Compression Therapy
9.3 Surgery
9.3.1 Lymphovenous Transplant
9.3.2 Lymphaticovenous Anastomosis
9.3.3 Liposuction
9.3.4 Others
9.4 Drug Therapy
9.4.1 Non-steroidal Anti-inflammatory Drugs (Nsaids)
9.4.2 Retinoids
9.4.3 Antibiotics
9.4.4 Others
9.5 Laser Therapy
9.6 Others
10 North America Lymphedema Treatment Market, By Type
10.1 Overview
10.2 Secondary Lymphedema
10.3 Primary Lymphedema
10.3.1 Lymphedema Praecox (Meige Disease)
10.3.2 Congenital Lymphedema
10.3.3 Lymphedema Tarda
11 North America Lymphedema Treatment Market, By Affected Area
11.1 Overview
11.2 Lower Extremity
11.3 Upper Extremity
11.4 Genitalia
12 North America Lymphedema Treatment Market, By Age Group
12.1 Overview
12.2 Adult
12.3 Geriatric
12.4 Pediatric
13 North America Lymphedema Treatment Market, By Route Of Administration
13.1 Overview
13.2 Oral
13.3 Injectable
13.4 Topical
14 North America Lymphedema Treatment Market, By End User
14.1 Overview
14.2 Hospital
14.3 Specialty Clinics
14.4 Ambulatory Surgical Centers
14.5 Others
15 North America Lymphedema Treatment Market, By Distribution Channel
15.1 Overview
15.2 Pharmacy Stores
15.3 Direct Tender
15.4 Others
16 North America Lymphedema Treatment Market, By Region
16.1 North America
16.1.1 U.S.
16.1.2 Canada
16.1.3 Mexico
17 North America Lymphedema Treatment Market, Company Landscape
17.1 Company Share Analysis: North America
18 Company Profile
18.1 Tactile Medical
18.1.1 Company Snapshot
18.1.2 Revenue Analysis
18.1.3 Company Share Analysis
18.1.4 Product Portfolio
18.1.5 Recent Development
18.2 Essity (Bsn Medical Gmbh)
18.2.1 Company Snapshot
18.2.2 Company Share Analysis
18.2.3 Product Portfolio
18.2.4 Recent Development
18.3 3m
18.3.1 Company Snapshot
18.3.2 Revenue Analysis
18.3.3 Company Share Analysis
18.3.4 Product Portfolio
18.3.5 Recent Developments
18.4 Cardinal Health
18.4.1 Company Snapshot
18.4.2 Revenue Analysis
18.4.3 Company Share Analysis
18.4.4 Product Portfolio
18.4.5 Recent Development
18.5 Lohmann & Rauscher Gmbh & Co. Kg
18.5.1 Company Snapshot
18.5.2 Company Share Analysis
18.5.3 Product Portfolio
18.5.4 Recent Development 118 
18.6 Airos Medical, Inc.
18.6.1 Company Snapshot
18.6.2 Product Portfolio
18.6.3 Recent Development
18.7 Avet Pharmaceuticals Inc.
18.7.1 Company Snapshot
18.7.2 Product Portfolio
18.7.3 Recent Development
18.8 Biocompression Systems
18.8.1 Company Snapshot
18.8.2 Product Portfolio
18.8.3 Recent Development
18.9 Convatec Inc.
18.9.1 Company Snapshot
18.9.2 Product Portfolio
18.9.3 Recent Development
18.10 Herantis Pharma Plc
18.10.1 Company Snapshot
18.10.2 Recent Development
18.11 Huntleigh Healthcare Limited
18.11.1 Company Snapshot
18.11.2 Product Portfolio
18.11.3 Recent Development
18.12 Juzo
18.12.1 Company Snapshot
18.12.2 Product Portfolio
18.12.3 Recent Development
18.13 Koya Medical
18.13.1 Company Snapshot
18.13.2 Product Portfolio
18.13.3 Recent Development
18.14 Medi Gmbh & Co. Kg
18.14.1 Company Snapshot
18.14.2 Product Portfolio
18.14.3 Recent Development
18.15 Mego Afek Ltd
18.15.1 Company Snapshot
18.15.2 Product Portfolio
18.15.3 Recent Development 129 
18.16 Paul Hartmann Ag
18.16.1 Company Snapshot
18.16.2 Revenue Analysis
18.16.3 Product Portfolio
18.16.4 Recent Developments
18.17 Sanyleg Srl A Socio Unico
18.17.1 Company Snapshot
18.17.2 Product Portfolio
18.17.3 Recent Development
18.18 Sigvaris Group
18.18.1 Company Snapshot
18.18.2 Product Portfolio
18.18.3 Recent Developments
18.19 Smith +Nephew
18.19.1 Company Snapshot
18.19.2 Revenue Analysis
18.19.3 Product Portfolio
18.19.4 Recent Development
18.20 Thermotek
18.20.1 Company Snapshot
18.20.2 Product Portfolio
18.20.3 Recent Development
19 Questionnaire
20 Related Reports
List Of Tables
Table 1 Pipeline Analysis For Lymphedema Treatment:
Table 2 An Annual Survey Of Hospitals In The U.S., Published In 2021
Table 3 North America Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 4 North America Compression Therapy In Lymphedema Treatment Market, By Region 2021-2030 (Usd Thousand)
Table 5 North America Compression Therapy In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 6 North America Compression Garments In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 7 North America Compression Therapy In Lymphedema Treatment Market, By Technique, 2021-2030 (Usd Thousand)
Table 8 North America Surgery In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 9 North America Surgery In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 10 North America Drug Therapy In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 11 North America Drug Therapy In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 12 North America Laser Therapy In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 13 North America Others In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 14 North America Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 15 North America Secondary Lymphedema In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 16 North America Primary Lymphedema In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 17 North America Primary Lymphedema In Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 18 North America Lymphedema Treatment Market, By Affected Area, 2021-2030 (Usd Thousand)
Table 19 North America Lower Extremity In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 20 North America Upper Extremity In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 21 North America Genitalia In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 22 North America Lymphedema Treatment Market, By Age Group, 2021-2030 (Usd Thousand)
Table 23 North America Adult In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 24 North America Geriatric In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 25 North America Pediatric In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 26 North America Lymphedema Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 27 North America Oral In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 28 North America Injectable In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 29 North America Topical In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 30 North America Lymphedema Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 31 North America Hospital In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 32 North America Speciality Clinics In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 33 North America Ambulatory Surgical Centers In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 34 North America Others In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 35 North America Lymphedema Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 36 North America Pharmacy Stores In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 37 North America Direct Tender In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 38 North America Others In Lymphedema Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 39 North America Lymphedema Treatment Market, By Country, 2021-2030 (Usd Thousand)
Table 40 North America Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 41 North America Compression Therapy In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 42 North America Compression Garments In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 43 North America Compression Therapy In Lymphedema Treatment Market, By Technique, 2021-2030 (Usd Thousand)
Table 44 North America Surgery In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 45 North America Drug Therapy In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 46 North America Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 47 North America Primary Lymphedema In Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 48 North America Lymphedema Treatment Market, By Affected Area, 2021-2030 (Usd Thousand)
Table 49 North America Lymphedema Treatment Market, By Age Group, 2021-2030 (Usd Thousand)
Table 50 North America Lymphedema Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 51 North America Lymphedema Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 52 North America Lymphedema Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 53 U.S. Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 54 U.S. Compression Therapy In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 55 U.S. Compression Garments In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 56 U.S. Compression Therapy In Lymphedema Treatment Market, By Technique, 2021-2030 (Usd Thousand)
Table 57 U.S. Surgery In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 58 U.S. Drug Therapy In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 59 U.S. Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 60 U.S. Primary Lymphedema In Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 61 U.S. Lymphedema Treatment Market, By Affected Area, 2021-2030 (Usd Thousand)
Table 62 U.S. Lymphedema Treatment Market, By Age Group, 2021-2030 (Usd Thousand)
Table 63 U.S. Lymphedema Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 64 U.S. Lymphedema Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 65 U.S. Lymphedema Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 66 Canada Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 67 Canada Compression Therapy In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 68 Canada Compression Garments In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 69 Canada Compression Therapy In Lymphedema Treatment Market, By Technique, 2021-2030 (Usd Thousand)
Table 70 Canada Surgery In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 71 Canada Drug Therapy In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 72 Canada Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 73 Canada Primary Lymphedema In Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 74 Canada Lymphedema Treatment Market, By Affected Area, 2021-2030 (Usd Thousand)
Table 75 Canada Lymphedema Treatment Market, By Age Group, 2021-2030 (Usd Thousand)
Table 76 Canada Lymphedema Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 77 Canada Lymphedema Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 78 Canada Lymphedema Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 79 Mexico Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 80 Mexico Compression Therapy In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 81 Mexico Compression Garments In Lymphedema Treatment Market, By Product, 2021-2030 (Usd Thousand)
Table 82 Mexico Compression Therapy In Lymphedema Treatment Market, By Technique, 2021-2030 (Usd Thousand)
Table 83 Mexico Surgery In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 84 Mexico Drug Therapy In Lymphedema Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 85 Mexico Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 86 Mexico Primary Lymphedema In Lymphedema Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 87 Mexico Lymphedema Treatment Market, By Affected Area, 2021-2030 (Usd Thousand)
Table 88 Mexico Lymphedema Treatment Market, By Age Group, 2021-2030 (Usd Thousand)
Table 89 Mexico Lymphedema Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 90 Mexico Lymphedema Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 91 Mexico Lymphedema Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 North America Lymphedema Treatment Market: Segmentation
Figure 2 North America Lymphedema Treatment Market: Data Triangulation
Figure 3 North America Lymphedema Treatment Market: Droc Analysis
Figure 4 North America Lymphedema Treatment Market: North America Vs Regional Analysis
Figure 5 North America Lymphedema Treatment Market: Company Research Analysis
Figure 6 North America Lymphedema Treatment Market: Interview Demographics
Figure 7 North America Lymphedema Treatment Market: Dbmr Market Position Grid
Figure 8 North America Lymphedema Treatment Market: Market End User Coverage Grid
Figure 9 North America Lymphedema Treatment Market: Vendor Share Analysis
Figure 10 North America Lymphedema Treatment Market: Segmentation
Figure 11 Increasing Prevalence Of Lymphedema And Rising Healthcare Expenditure Are Expected To Drive The Growth Of The North America Lymphedema Treatment Market In The Forecast Period Of 2023 To 2030
Figure 12 The Compression Therapy Segment Is Expected To Account For The Largest Share Of The North America Lymphedema Treatment Market In 2023 And 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of North America Lymphedema Treatment Market
Figure 14 North America Lymphedema Treatment Market: By Treatment Type, 2022
Figure 15 North America Lymphedema Treatment Market: By Type, 2022
Figure 16 North America Lymphedema Treatment Market: By Affected Area, 2022
Figure 17 North America Lymphedema Treatment Market: By Age Group, 2022
Figure 18 North America Lymphedema Treatment Market: By Route Of Administration, 2022
Figure 19 North America Lymphedema Treatment Market: By End User, 2022
Figure 20 North America Lymphedema Treatment Market: By Distribution Channel, 2022
Figure 21 North America Lymphedema Treatment Market: Company Share 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us